These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 37261217)

  • 1. Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-
    He J; Cui J; Shi Y; Wang T; Xin J; Li Y; Shan X; Zhu Z; Gao Y
    J Diabetes Res; 2023; 2023():7423661. PubMed ID: 37261217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 3. Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis.
    Fu Y; Cao J; Wei X; Ge Y; Su Z; Yu D
    Int Immunopharmacol; 2023 May; 118():110105. PubMed ID: 37018977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
    Sun L; Ding M; Chen F; Zhu D; Xie X
    PeerJ; 2023; 11():e14826. PubMed ID: 36815984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NLRP3 inflammasome ameliorates podocyte damage by suppressing lipid accumulation in diabetic nephropathy.
    Wu M; Yang Z; Zhang C; Shi Y; Han W; Song S; Mu L; Du C; Shi Y
    Metabolism; 2021 May; 118():154748. PubMed ID: 33675822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM29 promotes podocyte pyroptosis in diabetic nephropathy through the NF-kB/NLRP3 inflammasome pathway.
    Xu X; Qin Z; Zhang C; Mi X; Zhang C; Zhou F; Wang J; Zhang L; Hua F
    Cell Biol Int; 2023 Jun; 47(6):1126-1135. PubMed ID: 36841942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.
    Gao Y; Ma Y; Xie D; Jiang H
    Int Immunopharmacol; 2022 Jun; 107():108711. PubMed ID: 35338958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
    Lei Q; Yi T; Chen C
    Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin protects obesity-related glomerulopathy by inhibiting ROS/NF-κB/NLRP3 inflammation pathway.
    Xu X; Huang X; Zhang L; Huang X; Qin Z; Hua F
    BMC Nephrol; 2021 Jun; 22(1):218. PubMed ID: 34107901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV Alleviates Podocyte Injury in Diabetic Nephropathy through Regulating IRE-1α/NF-κ B/NLRP3 Pathway.
    Sun DL; Guo ZY; Liu WY; Zhang L; Zhang ZY; Hu YL; Li SF; Zhang MY; Zhang G; Wang JJ; Fang JA
    Chin J Integr Med; 2024 Jul; ():. PubMed ID: 39039342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic Acid Induces Podocyte Pyroptosis in Diabetic Nephropathy by an Increase of Egr1 Expression via Downregulation of EzH2.
    Kim D; Ban KY; Lee GH; Jun HS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy.
    Xu X; Zhang L; Hua F; Zhang C; Zhang C; Mi X; Qin N; Wang J; Zhu A; Qin Z; Zhou F
    Exp Cell Res; 2021 Nov; 408(2):112863. PubMed ID: 34626587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloquinoline quinone ameliorates renal fibrosis in diabetic nephropathy by inhibiting the pyroptosis pathway in C57BL/6 mice and human kidney 2 cells.
    Qu X; Zhai B; Liu Y; Chen Y; Xie Z; Wang Q; Wu Y; Liu Z; Chen J; Mei S; Wu J; You Z; Yu Y; Wang Y
    Biomed Pharmacother; 2022 Jun; 150():112998. PubMed ID: 35489281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spop ameliorates diabetic nephropathy through restraining NLRP3 inflammasome.
    Wang B; Dai Z; Gao Q; Liu Y; Gu G; Zheng H
    Biochem Biophys Res Commun; 2022 Feb; 594():131-138. PubMed ID: 35081502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis B virus X protein promotes podocyte pyroptosis in hepatitis B virus-associated glomerulonephritis by down-regulating microRNA -223 targeting NLRP3 inflammasome].
    Yu YN; Chen YQ; Li BS; Yang XQ; Feng MX; Jiang W
    Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 39(1):20-31. PubMed ID: 36776011
    [No Abstract]   [Full Text] [Related]  

  • 19. Astragaloside IV ameliorates diabetic nephropathy in
    Feng H; Zhu X; Tang Y; Fu S; Kong B; Liu X
    Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34278447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes.
    Qiu Z; He Y; Ming H; Lei S; Leng Y; Xia ZY
    J Diabetes Res; 2019; 2019():8151836. PubMed ID: 30911553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.